P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorou
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Accession was a born from a passion and a vision. A passion to harness the power of market access to ensure patients gain access to life changing medicines and devices….
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences through meaningful digital experiences. Our teams of specialists help clients…
We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…
Advertising, Branding, Clinical Research, Conference/meetings/events, Creative and design, Digital communications, Management consultancies, Market access, Market research, Marketing consultancies, Medical communications, Medical education, Patient support and adherence, Public relations, Regulatory affairs
We are market research experts in the healthcare, pharmaceutical, device and diagnostics space, and have a wealth of experience in a wide range of therapy areas. Our scientifically grounded approaches…
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value by involving patients throughout the entire product life cycle. We…
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…
Visions4Health are market access experts and your gateway to local adoption at pace. Leveraging our lived experience, understanding of national and local healthcare systems, and insights generated by our stakeholder…
Company Details
Latest Content from PMHub
White Papers and Resources | April 24, 2014 | Havas Lynx
Applying science to the creative process to improve lives
White Papers and Resources | March 31, 2014 | Havas Lynx
Unlocking better outcomes in healthcare with UX
White Papers and Resources | March 31, 2014 | Havas Lynx
Unlocking better outcomes in healthcare with UX
White Papers and Resources | January 3, 2014 | Havas Lynx
Better for patients, better for business
White Papers and Resources | January 3, 2014 | Havas Lynx
Our point of view
White Papers and Resources | January 3, 2014 | Havas Lynx
The case to embrace going social
White Papers and Resources | January 3, 2014 | Havas Lynx
Today, we’re focussed on getting to know our new target: she’s online, mobile, and connected to a large network of friends, information, and marketers who help her make decisions about...
White Papers and Resources | December 19, 2013 | Inizio
A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation...
White Papers and Resources | December 19, 2013 | Inizio
Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.
White Papers and Resources | November 22, 2013 | Inizio
How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from...